WEKO3
インデックスリンク
アイテム
{"_buckets": {"deposit": "dbc77e6a-a862-48e7-bf3e-06b471dac5cd"}, "_deposit": {"created_by": 3, "id": "13103", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "13103"}, "status": "published"}, "_oai": {"id": "oai:kanazawa-u.repo.nii.ac.jp:00013103", "sets": ["1134"]}, "author_link": ["20762", "20760", "20757", "20266", "20761", "20759", "20758", "389"], "item_4_biblio_info_8": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1983-01-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "11", "bibliographicPageEnd": "613", "bibliographicPageStart": "609", "bibliographicVolumeNumber": "308", "bibliographic_titles": [{"bibliographic_title": "New England Journal of Medicine"}]}]}, "item_4_description_21": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "We studied the effects of the bile acid sequestrant cholestyramine, alone and in combination with the experimental agent compactin (ML-236B), a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on serum levels of lipoproteins in 10 heterozygous patients with familial hypercholesterolemia. After cholestyramine treatment alone for 2 to 16 months, serum total and low-density lipoprotein cholesterol decreased by 20 and 28 per cent, respectively. With the addition of compactin for 12 weeks there was a 39 per cent total decrease in serum cholesterol from the control value - from 356 ± 14 to 217 ± 10 mg per deciliter (9.27 ± 0.36 to 5.64 ± 0.26 nmol per liter [mean ± S.E.M.]; P \u003c 0.001) - and a 53 per cent decrease in low-density lipoprotein cholesterol - from 263 ± 13 to 125 ± 10 mg per deciliter (6.84 ± 0.34 to 3.25 ± 0.26 nmol per liter; P \u003c 0.001). High-density lipoprotein cholesterol, which had increased during cholestyramine treatment, remained at its higher level. No adverse effects were observed. If long-term safety can be demonstrated, the compactin-cholestyramine regimen may prove useful in heterozygous familial hypercholesterolemia.", "subitem_description_type": "Abstract"}]}, "item_4_publisher_17": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Massachusetts Medical Society"}]}, "item_4_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1056/nejm198303173081101", "subitem_relation_type_select": "DOI"}}]}, "item_4_source_id_11": {"attribute_name": "NCID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00755156", "subitem_source_identifier_type": "NCID"}]}, "item_4_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0028-4793", "subitem_source_identifier_type": "ISSN"}]}, "item_4_version_type_25": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Mabuchi, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "389", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "00019960", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=00019960"}, {"nameIdentifier": "00019960", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000000019960"}]}, {"creatorNames": [{"creatorName": "Sakai, Takeshi"}], "nameIdentifiers": [{"nameIdentifier": "20757", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sakai, Yasuyuki"}], "nameIdentifiers": [{"nameIdentifier": "20758", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yoshimura, Akira"}], "nameIdentifiers": [{"nameIdentifier": "20759", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Watanabe, Akira"}], "nameIdentifiers": [{"nameIdentifier": "20760", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Wakasugi, Takanobu"}], "nameIdentifiers": [{"nameIdentifier": "20761", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Koizumi, Junji"}], "nameIdentifiers": [{"nameIdentifier": "20266", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "20161846", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=20161846"}, {"nameIdentifier": "20161846", "nameIdentifierScheme": "研究者番号", "nameIdentifierURI": "https://nrid.nii.ac.jp/nrid/1000020161846"}]}, {"creatorNames": [{"creatorName": "Takeda, Ryoyu"}], "nameIdentifiers": [{"nameIdentifier": "20762", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-10-03"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "ME-PR-MABUCHI-H-609.pdf", "filesize": [{"value": "545.4 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 545400.0, "url": {"label": "ME-PR-MABUCHI-H-609.pdf", "url": "https://kanazawa-u.repo.nii.ac.jp/record/13103/files/ME-PR-MABUCHI-H-609.pdf"}, "version_id": "1f3da3b1-e97c-43eb-a18f-8964aaac7d7e"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine"}]}, "item_type_id": "4", "owner": "3", "path": ["1134"], "permalink_uri": "http://hdl.handle.net/2297/9917", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-10-03"}, "publish_date": "2017-10-03", "publish_status": "0", "recid": "13103", "relation": {}, "relation_version_is_last": true, "title": ["Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine"], "weko_shared_id": 3}
Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine
http://hdl.handle.net/2297/9917
http://hdl.handle.net/2297/9917f9921165-2155-446c-a036-86c5bea31e55
名前 / ファイル | ライセンス | アクション |
---|---|---|
ME-PR-MABUCHI-H-609.pdf (545.4 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-10-03 | |||||
タイトル | ||||||
タイトル | Reduction of serum cholesterol in heterozygous patients with familial hypercholesterolemia. Additive effects of compactin and cholestyramine | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Mabuchi, Hiroshi
× Mabuchi, Hiroshi× Sakai, Takeshi× Sakai, Yasuyuki× Yoshimura, Akira× Watanabe, Akira× Wakasugi, Takanobu× Koizumi, Junji× Takeda, Ryoyu |
|||||
書誌情報 |
New England Journal of Medicine 巻 308, 号 11, p. 609-613, 発行日 1983-01-01 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0028-4793 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA00755156 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1056/nejm198303173081101 | |||||
出版者 | ||||||
出版者 | Massachusetts Medical Society | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | We studied the effects of the bile acid sequestrant cholestyramine, alone and in combination with the experimental agent compactin (ML-236B), a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on serum levels of lipoproteins in 10 heterozygous patients with familial hypercholesterolemia. After cholestyramine treatment alone for 2 to 16 months, serum total and low-density lipoprotein cholesterol decreased by 20 and 28 per cent, respectively. With the addition of compactin for 12 weeks there was a 39 per cent total decrease in serum cholesterol from the control value - from 356 ± 14 to 217 ± 10 mg per deciliter (9.27 ± 0.36 to 5.64 ± 0.26 nmol per liter [mean ± S.E.M.]; P < 0.001) - and a 53 per cent decrease in low-density lipoprotein cholesterol - from 263 ± 13 to 125 ± 10 mg per deciliter (6.84 ± 0.34 to 3.25 ± 0.26 nmol per liter; P < 0.001). High-density lipoprotein cholesterol, which had increased during cholestyramine treatment, remained at its higher level. No adverse effects were observed. If long-term safety can be demonstrated, the compactin-cholestyramine regimen may prove useful in heterozygous familial hypercholesterolemia. | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 |